scholarly article | Q13442814 |
P2093 | author name string | Y Ji | |
R Chen | |||
W P Fay | |||
O Adeola | |||
T L Strawn | |||
S S Jeong | |||
P2860 | cites work | The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. | Q30448825 |
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion | Q30477474 | ||
Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats. | Q34020021 | ||
Extracellular nucleotide and nucleoside signaling in vascular and blood disease | Q34047834 | ||
Mouse vein graft hemodynamic manipulations to enhance experimental utility | Q35071270 | ||
Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases | Q35089600 | ||
Contribution of endothelial injury and inflammation in early phase to vein graft failure: the causal factors impact on the development of intimal hyperplasia in murine models | Q35179817 | ||
Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
Coronary vein graft disease: pathogenesis and prevention | Q37215596 | ||
Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. | Q37218194 | ||
Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3. | Q37276960 | ||
Purinergic regulation of vascular tone and remodelling | Q37536253 | ||
Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity | Q37876541 | ||
Purinergic signaling and blood vessels in health and disease. | Q38171010 | ||
Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial. | Q38444455 | ||
Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition | Q39611446 | ||
The ADP antagonist MRS2179 regulates the phenotype of smooth muscle cells to limit intimal hyperplasia | Q41663331 | ||
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention | Q41729196 | ||
Human Umbilical Cord Blood–Derived Endothelial Cells Reendothelialize Vein Grafts and Prevent Thrombosis | Q41849182 | ||
Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts | Q42128982 | ||
P2Y11 impairs cell proliferation by induction of cell cycle arrest and sensitizes endothelial cells to cisplatin-induced cell death | Q42742419 | ||
C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts | Q42941011 | ||
Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk | Q43102079 | ||
Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. | Q43778731 | ||
Adenosine-induced increase in graft flow during coronary bypass surgery | Q44496945 | ||
A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. | Q50896016 | ||
Murine thrombosis models. | Q51251127 | ||
Macrophage depletion alters vein graft intimal hyperplasia. | Q53975070 | ||
Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells | Q67523058 | ||
Effects of adenine nucleotides on the proliferation of aortic endothelial cells | Q67718169 | ||
Adenosine and hypoxia stimulate proliferation and migration of endothelial cells | Q68498896 | ||
Experimental vein grafts in the rat: re-endothelialization and permeability to albumin | Q71660967 | ||
Adenosine stimulates proliferation of human endothelial cells in culture | Q72860000 | ||
Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function | Q73112984 | ||
Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors | Q74132799 | ||
CD39/vascular ATP diphosphohydrolase modulates xenograft survival | Q74146889 | ||
Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts | Q77924130 | ||
Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways | Q81668348 | ||
Human solCD39 inhibits injury-induced development of neointimal hyperplasia | Q82300172 | ||
Activity and expression of ecto-5'-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells | Q83827471 | ||
P433 | issue | 4 | |
P921 | main subject | thrombosis | Q261327 |
P304 | page(s) | 814-825 | |
P577 | publication date | 2017-02-23 | |
P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
P1476 | title | Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization | |
P478 | volume | 15 |
Search more.